(Q37864239)

English

A critical appraisal of the premotor symptoms of Parkinson's disease: potential usefulness in early diagnosis and design of neuroprotective trials

scientific article published on 11 April 2011

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

1 reference

Europe PubMed Central

A critical appraisal of the premotor symptoms of Parkinson's disease: potential usefulness in early diagnosis and design of neuroprotective trials (English)

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

0 references

Parkinson's disease

1 reference

based on heuristic

inferred from title

1

object named as

Anthony E Lang

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

language of work or name

0 references

publication date

11 April 2011

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

Movement Disorders

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

26

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

5

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

775-783

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

Overview of the extranigral aspects of Parkinson disease

1 reference

https://api.crossref.org/works/10.1002%2FMDS.23609

21 January 2018

Non-motor symptoms of Parkinson's disease: dopaminergic pathophysiology and treatment

1 reference

https://api.crossref.org/works/10.1002%2FMDS.23609

21 January 2018

Invited article: changing concepts in Parkinson disease: moving beyond the decade of the brain

1 reference

https://api.crossref.org/works/10.1002%2FMDS.23609

21 January 2018

Staging of brain pathology related to sporadic Parkinson's disease

1 reference

https://api.crossref.org/works/10.1002%2FMDS.23609

21 January 2018

Evidence that incidental Lewy body disease is pre-symptomatic Parkinson's disease

1 reference

https://api.crossref.org/works/10.1002%2FMDS.23609

21 January 2018

A critical evaluation of the Braak staging scheme for Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1002%2FMDS.23609

21 January 2018

Do alpha-synuclein aggregates in autonomic plexuses predate Lewy body disorders?: a cohort study.

1 reference

https://api.crossref.org/works/10.1002%2FMDS.23609

21 January 2018

The efficacy of combining several risk factors as a screening test

1 reference

https://api.crossref.org/works/10.1002%2FMDS.23609

21 January 2018

When can a risk factor be used as a worthwhile screening test?

1 reference

https://api.crossref.org/works/10.1002%2FMDS.23609

21 January 2018

Incidental Lewy body disease: clinical comparison to a control cohort

1 reference

https://api.crossref.org/works/10.1002%2FMDS.23609

21 January 2018

Neural control of the gastrointestinal tract: implications for Parkinson disease

1 reference

https://api.crossref.org/works/10.1002%2FMDS.23609

21 January 2018

Involvement of vagal autonomic nuclei in multiple system atrophy and Lewy body disease

1 reference

https://api.crossref.org/works/10.1002%2FMDS.23609

21 January 2018

Frequency of bowel movements and the future risk of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1002%2FMDS.23609

21 January 2018

Bowel movement frequency in late-life and incidental Lewy bodies

1 reference

https://api.crossref.org/works/10.1002%2FMDS.23609

21 January 2018

Medical records documentation of constipation preceding Parkinson disease: A case-control study

1 reference

https://api.crossref.org/works/10.1002%2FMDS.23609

21 January 2018

Bowel movement frequency in late-life and substantia nigra neuron density at death

1 reference

https://api.crossref.org/works/10.1002%2FMDS.23609

21 January 2018

MIBG scintigraphy for differentiating Parkinson's disease with autonomic dysfunction from Parkinsonism-predominant multiple system atrophy.

1 reference

https://api.crossref.org/works/10.1002%2FMDS.23609

21 January 2018

Axonal alpha-synuclein aggregates herald centripetal degeneration of cardiac sympathetic nerve in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1002%2FMDS.23609

21 January 2018

The olfactory system and its disorders

1 reference

https://api.crossref.org/works/10.1002%2FMDS.23609

21 January 2018

Prevalence of smell loss in Parkinson's disease--a multicenter study

1 reference

https://api.crossref.org/works/10.1002%2FMDS.23609

21 January 2018

Detection of presymptomatic Parkinson's disease: combining smell tests, transcranial sonography, and SPECT.

1 reference

https://api.crossref.org/works/10.1002%2FMDS.23609

21 January 2018

Olfactory loss and nigrostriatal dopaminergic denervation in the elderly

1 reference

https://api.crossref.org/works/10.1002%2FMDS.23609

21 January 2018

Enlarged hyperechogenic substantia nigra is related to motor performance and olfaction in the elderly

1 reference

https://api.crossref.org/works/10.1002%2FMDS.23609

21 January 2018

Association of olfactory dysfunction with incidental Lewy bodies

1 reference

https://api.crossref.org/works/10.1002%2FMDS.23609

21 January 2018

Association of olfactory dysfunction with risk for future Parkinson's disease

1 reference

https://api.crossref.org/works/10.1002%2FMDS.23609

21 January 2018

Smell identification ability in twin pairs discordant for Parkinson's disease

1 reference

https://api.crossref.org/works/10.1002%2FMDS.23609

21 January 2018

Idiopathic hyposmia as a preclinical sign of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1002%2FMDS.23609

21 January 2018

Olfactory testing combined with dopamine transporter imaging as a method to detect prodromal Parkinson's disease

1 reference

https://api.crossref.org/works/10.1002%2FMDS.23609

21 January 2018

Excessive daytime sleepiness and subsequent development of Parkinson disease

1 reference

https://api.crossref.org/works/10.1002%2FMDS.23609

21 January 2018

Delayed emergence of a parkinsonian disorder in 38% of 29 older men initially diagnosed with idiopathic rapid eye movement sleep behaviour disorder

1 reference

https://api.crossref.org/works/10.1002%2FMDS.23609

21 January 2018

Quantifying the risk of neurodegenerative disease in idiopathic REM sleep behavior disorder

1 reference

https://api.crossref.org/works/10.1002%2FMDS.23609

21 January 2018

REM sleep behavior disorder preceding other aspects of synucleinopathies by up to half a century

1 reference

https://api.crossref.org/works/10.1002%2FMDS.23609

21 January 2018

Potential early markers of Parkinson disease in idiopathic REM sleep behavior disorder

1 reference

https://api.crossref.org/works/10.1002%2FMDS.23609

21 January 2018

Combination of 'idiopathic' REM sleep behaviour disorder and olfactory dysfunction as possible indicator for alpha-synucleinopathy demonstrated by dopamine transporter FP-CIT-SPECT.

1 reference

https://api.crossref.org/works/10.1002%2FMDS.23609

21 January 2018

Relevance of substantia nigra hyperechogenicity and reduced odor identification in idiopathic REM sleep behavior disorder

1 reference

https://api.crossref.org/works/10.1002%2FMDS.23609

21 January 2018

Midbrain hyperechogenicity in idiopathic REM sleep behavior disorder

1 reference

https://api.crossref.org/works/10.1002%2FMDS.23609

21 January 2018

Exploring the electrocardiogram as a potential tool to screen for premotor Parkinson's disease

1 reference

https://api.crossref.org/works/10.1002%2FMDS.23609

21 January 2018

Cardiac autonomic dysfunction in idiopathic REM sleep behavior disorder

1 reference

https://api.crossref.org/works/10.1002%2FMDS.23609

21 January 2018

Severity of REM atonia loss in idiopathic REM sleep behavior disorder predicts Parkinson disease

1 reference

https://api.crossref.org/works/10.1002%2FMDS.23609

21 January 2018

Premotor Parkinson's disease: clinical features, detection, and prospects for treatment.

1 reference

https://api.crossref.org/works/10.1002%2FMDS.23609

21 January 2018

Decreased striatal dopamine transporter uptake and substantia nigra hyperechogenicity as risk markers of synucleinopathy in patients with idiopathic rapid-eye-movement sleep behaviour disorder: a prospective study [corrected].

1 reference

https://api.crossref.org/works/10.1002%2FMDS.23609

21 January 2018

Substantia nigra echomorphology and motor cortex excitability.

1 reference

https://api.crossref.org/works/10.1002%2FMDS.23609

21 January 2018

Identifiers

10.1002/MDS.23609

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37864239&oldid=2113561367"